Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission

Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission

BACKGROUND: The role of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in children with high-risk (HR) T-cell acute lymphoblastic leukemia (T-ALL) in first complete remission (CR1) is still under evaluation. Moreover, relapse is the main factor affecting survival. This study aimed to...

Full description

Bibliographic Details
Main Authors: Bai, L. (Author), Cheng, Y. (Author), Huang, X. (Author), Jia, Y. (Author), Lu, A. (Author), Wang, Y. (Author), Wu, J. (Author), Xu, L. (Author), Zhang, L. (Author), Zhang, X. (Author), Zhang, Y. (Author), Zuo, Y. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Online Access:View Fulltext in Publisher

Similar Items

Similar Items